INTERNATIONAL PATENT: OYSTER POINT PHARMA, INC. FILES APPLICATION FOR "SIMPINICLINE ORAL FORMATIONS AND USE THEREOF"

GENEVA, April 20 -- OYSTER POINT PHARMA, INC. (202 Carnegie Center, Suite 106Princeton, NJ 08540) filed a patent application (PCT/US2025/049985) for "SIMPINICLINE ORAL FORMATIONS AND USE THEREOF" on Oct 08, 2025. With publication no. WO/2026/080563, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LOKHNAUTH, John (c/o Oyster Point Pharma, Inc.202 Carnegie Center, Suite 106Princeton, NJ 08540), EHRNSPERGER, Eric C. (c/o Oyster Point Pharma, Inc.202 Carnegie Center, Suite 106Princeton, NJ 08540), DONATO, George J. (c/o Oyste...